IGF1-LR3 Research Guide

What Is IGF-1 LR3?

IGF-1 LR3 (Long Arginine 3 Insulin-Like Growth Factor-1) is a synthetic analogue of Insulin-Like Growth Factor-1 (IGF-1), a naturally occurring peptide involved in cellular growth and development.

Developed through peptide engineering, IGF-1 LR3 incorporates structural modifications that distinguish it from naturally occurring IGF-1. These modifications have made it an important subject of scientific investigation within peptide, endocrine and cellular biology research.

Due to its unique structure and extensive presence within scientific literature, IGF-1 LR3 has become one of the most widely recognised compounds within insulin-like growth factor research.


Understanding How IGF-1 LR3 Works

IGF-1 LR3 is a modified analogue of naturally occurring Insulin-Like Growth Factor-1.

Researchers have investigated how insulin-like growth factors interact with the Insulin-Like Growth Factor-1 Receptor (IGF-1R), a receptor involved in numerous cellular signalling pathways.

Compared with endogenous IGF-1, IGF-1 LR3 contains an extended amino acid sequence and a substitution at the third amino acid position. These structural modifications have been widely studied due to their influence on the compound's biological characteristics.

Its interaction with IGF-1 receptors continues to make IGF-1 LR3 an important research compound.


Why Researchers Study IGF-1 LR3

IGF-1 LR3 has been investigated across numerous scientific disciplines, including:

  • Cellular signalling
  • Growth factor biology
  • Endocrine research
  • Cell proliferation studies
  • Receptor interaction research
  • Molecular biology
  • Peptide engineering

Its structural modifications and extensive scientific history continue to make IGF-1 LR3 a significant subject of laboratory investigation.


What Does LR3 Mean?

One of the most common questions surrounding this compound is the meaning of "LR3."

LR stands for Long Arginine, referring to the additional amino acids incorporated into the peptide.

3 refers to the substitution of arginine at the third amino acid position.

These modifications distinguish IGF-1 LR3 from naturally occurring IGF-1 and are responsible for many of the characteristics that researchers investigate.


What Makes IGF-1 LR3 Different?

Unlike naturally occurring IGF-1, IGF-1 LR3 has been structurally modified through peptide engineering.

These modifications include an extended amino acid sequence and a substitution within the peptide structure, making it distinct from endogenous IGF-1.

Its synthetic design and interaction with IGF-1 receptors have made it one of the most widely studied growth factor analogues within peptide research.


IGF-1 LR3 Compared to Other Research Peptides

IGF-1 LR3

A synthetic analogue of Insulin-Like Growth Factor-1 developed through structural modification.

IGF-1

A naturally occurring growth factor involved in cellular signalling and development.

Tesamorelin

A synthetic Growth Hormone Releasing Hormone (GHRH) analogue investigated within endocrine research.

Ipamorelin

A Growth Hormone Releasing Peptide (GHRP) studied for its interaction with the ghrelin receptor pathway.

Each compound possesses a unique structure, mechanism and area of scientific investigation.


Product Specifications

Compound: IGF-1 LR3

Alternative Name: Long Arginine 3 Insulin-Like Growth Factor-1

Quantity: 1mg

Form: Lyophilised powder

Appearance: White to off-white powder

Storage: Store refrigerated upon receipt

Testing: Independently batch tested

Research Classification: Synthetic Growth Factor Analogue


Independent Batch Testing

At Platinum Peptides, transparency and quality assurance remain central to our approach.

Every batch undergoes independent third-party analytical testing to verify identity and purity before being released.

Why Batch Testing Matters

Identity Verification

Confirms that the material matches the labelled compound.

Purity Analysis

Provides confidence that the sample meets established quality standards.

Consistency

Helps ensure batch-to-batch reliability and reproducibility.

Transparency

Allows researchers to review independent analytical data before making purchasing decisions.

Certificates of Analysis are available for each batch where applicable.


Storage Information

Lyophilised research compounds should be stored in a cool, dry environment and protected from excessive heat, moisture and direct sunlight.

Researchers should always review appropriate storage conditions relevant to their specific protocols and applications.


Frequently Asked Questions

What is IGF-1 LR3?

IGF-1 LR3 is a synthetic analogue of Insulin-Like Growth Factor-1 that has been structurally modified for scientific research.

What does LR3 stand for?

LR3 stands for Long Arginine 3, referring to the structural modifications incorporated into the peptide.

Is IGF-1 LR3 naturally occurring?

No. IGF-1 LR3 is a synthetic analogue developed from naturally occurring IGF-1.

What is the difference between IGF-1 and IGF-1 LR3?

IGF-1 LR3 contains structural modifications, including an extended amino acid sequence and an amino acid substitution, which distinguish it from naturally occurring IGF-1.

What type of compound is IGF-1 LR3?

IGF-1 LR3 is classified as a synthetic growth factor analogue.

Is IGF-1 LR3 batch tested?

Yes. Platinum Peptides uses independent third-party testing to verify batch quality and purity.

How should IGF-1 LR3 be stored?

Store in accordance with established storage guidelines and maintain refrigeration where appropriate.


Related Research Compounds

Researchers interested in IGF-1 LR3 may also wish to explore:


Important Information

This product is supplied strictly for laboratory research purposes only.

It is not intended for human consumption, therapeutic use, diagnostic use or veterinary use.

Researchers are responsible for ensuring compliance with all applicable laws, regulations and research protocols relating to the handling and use of peptide compounds.

Platinum Peptides does not provide guidance regarding dosage, administration, usage protocols or expected effects. Researchers are responsible for conducting their own independent research.